Stable brain ATM message and residual kinase-active ATM protein in ataxia-telangiectasia

Journal of Neuroscience

Volumn 31, Issue 20, 2011, Pages 7568-7577

  Li, Jiali ^a   Chen, Jianmin ^a   Vinters, Harry V ^b   Gatti, Richard A ^b   Herrup, Karl ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; MESSENGER RNA; PROTEIN P53;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; BRAIN CORTEX; BRAIN DEGENERATION; CATALYSIS; CELL CYCLE REGULATION; CEREBELLUM; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC ENGINEERING; HUMAN; HUMAN TISSUE; MALE; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADOLESCENT; ADULT; ANIMALS; ATAXIA TELANGIECTASIA; BRAIN; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; PHOSPHOTRANSFERASES; PREGNANCY; PROTEIN-SERINE-THREONINE KINASES; RNA STABILITY; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 79956308086     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0778-11.2011     Document Type: Article

References (23)

1. Alterman N, Fattal-Valevski A, Moyal L, Crawford TO, Lederman HM, Ziv Y, Shiloh Y (2007) Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype. Am J Med Genet A 143A:1827-1834.
2. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171.
3. Barlow C, Ribaut-Barassin C, Zwingman TA, Pope AJ, Brown KD, Owens JW, Larson D, Harrington EA, Haeberle AM, Mariani J, Eckhaus M, Herrup K, Bailly Y, Wynshaw-Boris A (2000) ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci U S A 97:871-876.
4. Boder E (1975) Ataxia-telangiectasia: some historic, clinical and pathologic observations. Birth Defects Orig Artic Ser 11:255-270.
5. Boder E, Sedgwick RP (1958) Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526-554.
6. Borghesani PR, Alt FW, Bottaro A, Davidson L, Aksoy S, Rathbun GA, Roberts TM, Swat W, Segal RA, Gu Y (2000) Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc Natl Acad Sci U S A 97:3336-3341.
7. Bundey S (1994) Clinical and genetic features of ataxia-telangiectasia. Int J Radiat Biol 66:S23-29.
8. Chun HH, Sun X, Nahas SA, Teraoka S, Lai CH, Concannon P, Gatti RA (2003) Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab 80:437-443.
9. Dar I, Biton S, Shiloh Y, Barzilai A (2006) Analysis of the ataxia telangiectasia mutated-mediated DNA damage response in murine cerebellar neurons. J Neurosci 26:7767-7774.
10. Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P (1996) Pleiotropic defects in ataxia-telangiectasia proteindeficient mice. Proc Natl Acad Sci U S A 93:13084-13089.
11. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K, Lathrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, Susi E, et al. (1988) Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336:577-580.
12. Gatti RA, Nieberg R, Boder E (1989) Uterine tumors in ataxiatelangiectasia. Gynecol Oncol 32:257-260.
13. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ (1998) Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089-1091.
14. Kozlov SV, Graham ME, Peng C, Chen P, Robinson PJ, Lavin MF (2006) Involvement of novel autophosphorylation sites in ATM activation. EMBO J 25:3504-3514.
15. Kuljis RO, Xu Y, Aguila MC, Baltimore D (1997) Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc Natl Acad Sci U S A 94:12688-12693.
16. Lavin MF, Shiloh Y (1997) The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177-202.
17. Li A, Swift M (2000) Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am J Med Genet 92:170-177.
18. Li J, Han YR, Plummer MR, Herrup K (2009) Cytoplasmic ATM in neurons modulates synaptic function. Curr Biol 19:2091-2096.
19. Sandoval N, Platzer M, Rosenthal A, Dörk T, Bendix R, Skawran B, Stuhrmann M, Wegner RD, Sperling K, Banin S, Shiloh Y, Baumer A, Bernthaler U, Sennefelder H, Brohm M, Weber BH, Schindler D (1999) Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8:69-79.
20. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
21. Sedgwick RP, Boder E (1960) Progressive ataxia in childhood with particular reference to ataxia-telangiectasia. Neurology 10:705-715.
22. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D (1996) Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 10:2411-2422.
23. Yang Y, Herrup K (2005) Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J Neurosci 25:2522-2529.